Lv4
464 积分 2025-03-31 加入
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
7天前
已完结
Plasma metabolites-based design of long-acting peptides and their anticancer evaluation
13天前
已完结
Prediction of the pharmacokinetics of the GLP-1 receptor agonist semaglutide in humans via a population pharmacokinetic model integrating interspecies scaling
1个月前
已完结
Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cells
1个月前
已关闭
The Crystal Structure of Phosphonate-Inhibited d-Ala-d-Ala Peptidase Reveals an Analogue of a Tetrahedral Transition State,
2个月前
已完结
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
2个月前
已完结
GLP ‐ 1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models
2个月前
已完结
Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species
4个月前
已完结
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations
5个月前
已完结
Next Generation Dual GLP-1/GIP, GLP-1/Glucagon, and Triple GLP-1/GIP/Glucagon Agonists: A Literature Review
10个月前
已完结
皖公网安备34019202002308
